Press release
Hyperlipidemia Drugs Market Report 2021-26: Industry Analysis, Share, Size, Growth and Forecast
Hyperlipidemia Drugs Market Research Report
Historical: 2015-2020
Base Year: 2020
Forecast Year: 2021-2026
Download free sample of the report: https://www.imarcgroup.com/hyperlipidemia-drugs-market/requestsample
Industry Definition and Application:
Hyperlipidemia refers to a health condition where an excessive quantity of lipids, such as cholesterol and triglycerides, is produced into the blood. This condition may lead to cardiac stroke, peripheral vascular disorders, atherosclerosis, diabetes, obesity, hypertension, and various cardiovascular diseases. Some of the hyperlipidemia drugs include statins, bile acid sequestrants, cholesterol absorption inhibitors, PCSK9 inhibitors, fibric acid derivatives, etc. These drugs help in reducing cholesterol production levels in the liver along with lowering the quantity of lipids from the bloodstream.
Browse full report with TOC: https://www.imarcgroup.com/hyperlipidemia-drugs-market
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends and Drivers:
The rising prevalence of numerous lifestyle disorders, such as hypertension, obesity, cardiovascular diseases, etc., due to sedentary consumer lifestyles, is driving the demand for hyperlipidemia drugs. Furthermore, the increasing geriatric population who are more prone to the risk of high cholesterol and cardiovascular diseases, is also augmenting the market growth. Additionally, the development of novel drug classes with improved endothelial function and stable atherosclerotic plaques is further propelling the demand for hyperlipidemia drugs. Besides this, the reduction in the prices of PCSK9 inhibitors, such as Repatha and Praluent, is expected to replace several expensive therapies, thereby catalyzing the global market for hyperlipidemia drugs.
Hyperlipidemia Drugs Market Segmentation:
The report has segmented on the basis of drug type, end-use and geography
Segmentation by Drug Type:
Statins
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
PCSK9 Inhibitors
Fibric Acid Derivatives
Others
Segmentation by End User:
Hospitals
Clinics
Others
Segmentation by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Who are the Major Hyperlipidemia Drugs Key players?
The report provides a detailed analysis of the market leaders, including.
• Amgen Inc.,
• AstraZeneca PLC,
• Daiichi Sankyo
• Company Limited,
• Eli Lilly and Company,
• Esperion Therapeutics Inc.,
• GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc),
• Immuron Limited,
• Ionis Pharmaceuticals Inc.,
• Merck & Co. Inc.,
• Pfizer Inc. and Sanofi S.A.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Browse related reports by IMARC Group:
Bariatric Surgery Devices Market Size: https://www.imarcgroup.com/bariatric-surgery-devices-market
Metabolomics Market Report: https://www.imarcgroup.com/metabolomics-market
Nicotine Gum Market Report: https://www.imarcgroup.com/nicotine-gum-market
Biopsy Devices Market Report: https://www.imarcgroup.com/biopsy-devices-market
Human Insulin Market Report: https://www.imarcgroup.com/human-insulin-market
Medical Billing Outsourcing Market Report: https://www.imarcgroup.com/medical-billing-outsourcing-market
Respiratory Diagnostics MarketReport : https://www.imarcgroup.com/respiratory-diagnostics-market
Cannula Market Report: https://www.imarcgroup.com/cannula-market
Isothermal Nucleic Acid Amplification Technology Market Report: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperlipidemia Drugs Market Report 2021-26: Industry Analysis, Share, Size, Growth and Forecast here
News-ID: 2450767 • Views: …
More Releases from IMARC Group
Detailed Project Report on Copper Tube Manufacturing Plant Setup by IMARC Group
IMARC Group's report titled "Copper Tube Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a copper tube manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging, and transportation requirements, and more.
In addition to…
Empty Capsule Manufacturing Plant Project Report 2024, Machinery, Cost Analysis …
IMARC Group's report titled "Empty Capsule Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a empty capsule manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.
In addition to…
Cellulose Manufacturing Plant Project Report 2024, Machinery, Cost and Raw Mater …
IMARC Group's report titled "Cellulose Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a cellulose manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.
In addition to the operational…
Thermal Drone Manufacturing Plant Project Report 2024: Business Plan and Raw Mat …
IMARC Group's report titled "Thermal Drone Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a thermal drone manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.
In addition to…
More Releases for Hyperlipidemia
Hyperlipidemia Drug Market Trends, Research Report, Growth, Opportunities, Forec …
The global hyperlipidemia drug market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the global hyperlipidemia market during the forecast period is the rapidly growing consumption of dairy products along with the sedentary lifestyle is fueling the market. Statins are the first line of treatment for hyperlipidemia. The expiration of patents of branded drugs will lead to the genericization…
Hyperlipidemia Drugs Market Size - Forecasts to 2026
As per the research conducted by GME, the Hyperlipidemia Drugs Market is estimated to be valued at USD 21.84 Billion in 2021 and is projected to reach USD 24.71 Billion by 2026 at a CAGR of 2.5%. increasing unusual cholesterol levels, upsurge in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) level cost-effective innovations, growing public awareness of nutraceuticals, increasing innovations in biotechnology, government initiatives, and increasing research and developments activities…
Global Hyperlipidemia Drug Market Size, Comprehensive Analysis & Forecast to 202 …
The global hyperlipidemia drug market is estimated to witness significant growth during the forecast period. The demand for a statin to manage cholesterol is driving the market growth across the globe. This drug supports lowering cholesterol, hence reduce the chances of cardiovascular diseases, stroke, and diabetes. Statins are used to manage the plaque on blood vessels and reduce the risk of blood clots. There are various statins options are available…
Hyperlipidemia Drugs Market - Operational challenges 2028 | Dr. Reddy's Laborato …
Global Hyperlipidemia Drugs Market: Overview
Hyperlipidemia is a technical term for abnormal amounts of fats (lipids) in the blood. The two noteworthy sorts of lipids found in the blood are triglycerides and cholesterol. Triglycerides are made when your body stores the additional calories it doesn't require for producing energy. They additionally come specifically from a man's eating routine in nourishments, for example, red meat and entire fat dairy. An eating regimen…
Hyperlipidemia Therapeutics Pipeline Review 2018 - Clinical Trials, Results, Des …
Hyperlipidemia refers to elevated amount of lipids and cholesterol in the bloodstream. The two major types of lipid abnormalities are characterized by either high blood levels of triglycerides (known as hypertriglyceridemia) or high blood cholesterol levels (known as hypercholesterolemia). Hyperlipidemia is often associated with increased risk of coronary heart disease and strokes. The study analyzed that hyperlipidemia therapeutics pipeline comprises 53 drug candidates in different stages of development.
Explore report sample…
Hyperlipidemia Prescription Drugs Market To Witness Exponential Growth By 2019
Hyperlipidemia refers to abnormal elevation of lipids and/or lipoprotein levels. Risk factors associated with such condition include stroke, peripheral vascular disease, atherosclerosis, diabetes, obesity, hypertension and other cardiovascular diseases. Drugs which are used to treat hyperlipidemia act by either accelerating the elimination of lipoproteins from the body or decrease production of lipoproteins. These medications not only lower the unwanted cholesterol levels but also prove to be vital for lowering the…
